A Clinical Study To Evaluate The Effect Of Dashamoola Taila Matra Basti In The Management Of PCOS Pushpaghni Jataharini
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
Polycystic Ovarian Syndrome (PCOS) is the most common endocrinopathy among women of reproductive age associated with lifestyle factors such as sedentary habits, increased intake of junk food and stress. According to WHO, Incidence of PCOS is 6 to 13 percent in women of reproductive age and upto 70 percent of cases are undiagnosed. The occurrence of PCOS in India varies significantly ranging from 3.7 percent to 22 percent. Exact pathophysiology of PCOS is not clearly understood. The medical intervention of PCOS is oral Contraceptives, Insulin Sensitizers, Aromatase inhibitors, Androgen receptor antagonists, Gonadotropin therapy, Surgical intervention Laparoscopic ovarian diathermy. These hormonal therapies have longterm health consequences, Hence researchers are looking to the Ayurveda medicines for the treatment of PCOS. In this study, Dashamoola Taila Matra Basti is administrated. The drugs of Dashamoola is Katu-tikta Rasa, Laghu-Ruksa Guna, Katu Vipaka and Ushna Virya, Dashamoola Taila drugs having the properties of Kapha Vatahara, Lekhaniya and also Dipana- Pachana. The present study is aimed to bring out the influence of Ayurveda in the management of PCOS. Dashamoola Taila Matra Basti resolves the ovarian volume, regularies the menstrual cycle and restore the ovulation. Since the prevalence of PCOS is high, the present study on A CLINICAL STUDY TO EVALUATE THE EFFECTIVNESS OF DASHAMOOLA TAILA MATRA BASTI IN THE MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME (PUSHPAGHNI JATAHARINI) is selected with a hope to provide better results through Ayurvedic system.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 40.00 Year(s)(—)
- 性别
- Female
入选标准
- •Age group between 16 to 40 years 2) Ultrasound findings of polycystic ovaries as per international criteria (ovarian volume & no of follicles) 3) Secondary amenorrhea due to PCOS 4) Oligomenorrhea due to PCOS.
排除标准
- •Age group below 16 years and above 40 years 2) primary amenorrhea 3) Thyroid disorder 4) Hyperprolactemia.
研究者
DR LEELA RAMAKRISHNAN
Room No 13 PG Department of Prasuti Tantra Evam Striroga Frist Floor Sri Jayendra Saraswathi Ayurveda College and Hospital Nazarathpettai Chennai-600123
